Characteristics of COX2 inhibitors questioned

被引：0
|
作者：
Sophie Petit-Zeman
机构：
来源：
Nature Reviews Drug Discovery | 2004年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A health watchdog agency's decision on COX2 inhibitors highlights the difference in opinion about the use of these treatments.
引用
收藏
页码：726 / 726
相关论文
共 50 条
  • [21] Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs?
    Bianca Rocca
    Giovanni Davì
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 316 - 317
  • [22] Oestrogen activates COX2 pathway
    Melanie Brazil
    [J]. Nature Reviews Drug Discovery, 2005, 4 : 16 - 16
  • [23] A COX2 molecular phylogeny of the peronosporomycetes
    Hudspeth, DSS
    Nadler, SA
    Hudspeth, MES
    [J]. MYCOLOGIA, 2000, 92 (04) : 674 - 684
  • [24] New clues in the COX2 mystery
    Peter Kirkpatrick
    [J]. Nature Reviews Drug Discovery, 2006, 5 : 4571 - 4571
  • [25] Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk:: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study
    Depont, F.
    Fourrier, A.
    Merliere, Y.
    Droz, C.
    Amouretti, M.
    Begaud, B.
    Benichou, J.
    Moride, Y.
    Velo, G. P.
    Sturkenboom, M.
    Blin, P.
    Moore, N.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (08) : 891 - 900
  • [26] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. HEADACHE, 2005, 45 (06): : 766 - 766
  • [27] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. HEADACHE, 2005, 45 (07): : 850 - 861
  • [28] Differential Effect of COX1 and COX2 Inhibitors on Renal Outcomes following Ischemic Acute Kidney Injury
    Bischoff, Ariane
    Bucher, Michael
    Gekle, Michael
    Sauvant, Christoph
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (01) : 1 - 11
  • [29] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. CEPHALALGIA, 2005, 25 (10) : 844 - 845
  • [30] COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib
    Emma Bell
    Frida Ponthan
    Claire Whitworth
    Deborah A. Tweddle
    John Lunec
    Christopher P. F. Redfern
    [J]. Clinical & Experimental Metastasis, 2014, 31 : 651 - 659
12345